These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20224258)

  • 1. Renal cell carcinoma and proteomics.
    Sandim V; Pereira DA; Ornellas AA; Alves G
    Urol Int; 2010; 84(4):373-7. PubMed ID: 20224258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic biomarkers in renal cell carcinoma.
    Jiang Z
    Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in renal cell carcinoma.
    Shuch BM; Lam JS; Belldegrun AS; Figlin RA
    Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma.
    Shah JB; Margulis V
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):837-42. PubMed ID: 20553209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers for predicting prognosis of renal cell carcinoma.
    Nogueira M; Kim HL
    Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic models and algorithms in renal cell carcinoma.
    Lane BR; Kattan MW
    Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting outcome in renal cell carcinoma.
    Sun M; Shariat SF; Karakiewicz PI
    Curr Opin Urol; 2010 Sep; 20(5):355-60. PubMed ID: 20592610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in clear cell renal cell carcinoma.
    George S; Bukowski RM
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1737-47. PubMed ID: 18062748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic markers in renal cell carcinoma.
    Ljungberg B
    Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.
    Okamura N; Masuda T; Gotoh A; Shirakawa T; Terao S; Kaneko N; Suganuma K; Watanabe M; Matsubara T; Seto R; Matsumoto J; Kawakami M; Yamamori M; Nakamura T; Yagami T; Sakaeda T; Fujisawa M; Nishimura O; Okumura K
    Proteomics; 2008 Aug; 8(15):3194-203. PubMed ID: 18615424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic prognostic indicators for renal cell carcinoma.
    Delahunt B
    Semin Diagn Pathol; 1998 Feb; 15(1):68-76. PubMed ID: 9503507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic molecular markers in renal cell carcinoma.
    Tunuguntla HS; Jorda M
    J Urol; 2008 Jun; 179(6):2096-102. PubMed ID: 18423738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.